Correlation Engine 2.0
Clear Search sequence regions


  • arthritis (2)
  • cellular (2)
  • female (1)
  • hdac inhibitors (4)
  • HDAC4 (1)
  • Hdac5 (1)
  • joint mice (1)
  • KLF2 (9)
  • Kruppel Like (2)
  • marrow (1)
  • mice (3)
  • monocytes (5)
  • osteoclasts (1)
  • pathogenesis (1)
  • protein level (1)
  • regulates (1)
  • rheumatoid arthritis (3)
  • serum (3)
  • spleen (1)
  • thymus (1)
  • Sizes of these terms reflect their relevance to your search.

    Krüppel-like factor 2 (KLF2) critically regulates activation and function of monocyte, which plays important pathogenic role in progressive joint destruction in rheumatoid arthritis (RA). It is yet to be established the molecular basis of KLF2-mediated regulation of monocytes in RA pathogenesis. Herein, we show that a class of compound, HDAC inhibitors (HDACi) induced KLF2 expression in monocytes both in vitro and in vivo. KLF2 level was also elevated in tissues, such as bone marrow, spleen and thymus in mice after infusion of HDACi. Importantly, HDACi significantly reduced osteoclastic differentiation of monocytes with the up-regulation of KLF2 and concomitant down-regulation of matrixmetalloproteinases both in the expression level as well as in the protein level. In addition, HDACi reduced K/BxN serum-induced arthritic inflammation and joint destruction in mice in a dose-dependent manner. Finally, co-immunoprecipitation and overexpression studies confirmed that KLF2 directly interacts with HDAC4 molecule in cells. These findings provide mechanistic evidence of KLF2-mediated regulation of K/BxN serum-induced arthritic inflammation. © 2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.

    Citation

    Manjusri Das, Dipranjan Laha, Suman Kanji, Matthew Joseph, Reeva Aggarwal, Obiajulu H Iwenofu, Vincent J Pompili, Mukesh K Jain, Hiranmoy Das. Induction of Krüppel-like factor 2 reduces K/BxN serum-induced arthritis. Journal of cellular and molecular medicine. 2019 Feb;23(2):1386-1395

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 30506878

    View Full Text